Abstract

Granisetron Hydrochloride 005 mg/mL in Ora-Sweet and Ora-Plus

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2022 - Volume 26, Number 6

Page(s): 513

Download in electronic PDF format for $75
  • Granisetron Hydrochloride 005 mg/mL in Ora-Sweet and Ora-Plus Page 1

Abstract

A formulation for preparing Granisetron Hydrochloride 005 mg/mL in Ora-Sweet and Ora-Plus. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • granisetron hydrochloride
  • vomiting
  • nausea
  • emesis
  • antiemetic agent
  • type 3 serotonergic receptor inhibitor
  • serotonin 5-HT3 receptor antagonist

Related Categories

  • CANCER AND AIDS
  • FORMULATIONS
  • GASTROENTEROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2022
Pg. 513
Granisetron Hydrochloride 005 mg/mL in Ora-Sweet and Ora-Plus
Author(s): Allen Loyd V Jr
Sep/Oct 2011
Pg. 419
Granisetron Hydrochloride 0.2-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2013
Pg. 66
Granisetron 1-mg/mL Injection
Author(s): Allen Loyd V Jr
Jan/Feb 2018
Pg. 86-94
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride
Author(s): Wu George, Powers Dan, Yeung Stanley, Chen Frank, Neelon Kelly
Sep/Oct 2019
Pg. 413
Verapamil Hydrochloride 50 mg/mL in Ora-Plus:Ora-Sweet (1:1)
Author(s): Allen Loyd V Jr
Jan/Feb 2023
Pg. 53
Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus
Author(s): Allen Loyd V Jr
Mar/Apr 2021
Pg. 144
Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension
Author(s): Allen Loyd V Jr
May/Jun 2006
Pg. 222
Granisetron 0.05-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
May/Jun 2019
Pg. 236
Sildenafil 2.5 mg/mL in Ora-Plus:Ora-Sweet
Author(s): Allen Loyd V Jr
Jan/Feb 2017
Pg. 76-82
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride
Author(s): Wu George, Yeung Stanley, Chen Frank
Sep/Oct 2018
Pg. 411
Torsemide 5 mg/mL in Ora-Plus:Ora-Sweet Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2022
Pg. 56
Enalapril Maleate 1 mg-mL in Ora-Plus and Ora-Sweet Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2018
Pg. 496
Hydroxyurea 100 mg/mL in Ora-Plus:Ora-Sweet, Ora-Plus: Ora-Sweet SF, Ora-Blend or Oral-Blend SF Oral Suspensions
Author(s): Allen Loyd V Jr
May/Jun 2005
Pg. 238-241
Physical and Chemical Stability of Palonosetron Hydrochloride with Topotecan Hydrochloride and Irinotecan Hydrochloride during Simulated Y-Site Administration
Author(s): Trissel Lawrence A, Xu Quanyun A
Jul/Aug 2012
Pg. 339
Ondansetron Hydrochloride 2-mg/mL Injection
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Jan/Feb 2018
Pg. 58
Thalidomide 20 mg/mL in Ora-Plus and Ora-Sweet Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2020
Pg. 132
Glycopyrrolate 0.2 mg/mL in Ora-Plus:Ora-Sweet (1:1)
Author(s): Allen Loyd V Jr
Jul/Aug 2020
Pg. 316
Hydroxychloroquine Sulfate 25 mg/mL in Ora-Plus:Ora-Sweet SF
Author(s): Allen Loyd V Jr
May/Jun 2022
Pg. 241
Valganciclovir 20 mg/mL in Ora-Plus and Ora-Sweet Suspension
Author(s): Allen Loyd V Jr